A 28-year-old primigravida at 34 weeks of gestation presents to the antenatal clinic with a complaint of headache and blurred vision for 2 days. On examination, her blood pressure is 168/112 mmHg (previous baseline 110/70 mmHg). Urine dipstick shows 2+ proteinuria. Reflexes are brisk with 3+ patellar reflexes. Laboratory investigations reveal platelet count 95,000/μL, serum creatinine 1.4 mg/dL (baseline 0.8 mg/dL), and AST 65 U/L. Fetal heart rate is 140 bpm with normal variability. What is the most appropriate immediate management?

Explanation

## Clinical Diagnosis This patient presents with **severe preeclampsia with HELLP syndrome features** at 34 weeks gestation. ### Key Diagnostic Criteria Met | Feature | Finding | Significance | |---------|---------|---------------| | **Hypertension** | 168/112 mmHg (≥160/110) | Severe range | | **Proteinuria** | 2+ on dipstick | Significant | | **Neurological** | Headache, blurred vision, hyperreflexia | Imminent eclampsia | | **Thrombocytopenia** | 95,000/μL | HELLP component | | **Hepatic involvement** | AST 65 U/L | HELLP component | | **Renal dysfunction** | Creatinine 1.4 mg/dL | Severe preeclampsia | **Key Point:** The presence of severe hypertension (≥160/110 mmHg) + proteinuria + symptoms of cerebral/visual involvement + laboratory derangements (thrombocytopenia, elevated transaminases, elevated creatinine) defines **severe preeclampsia with HELLP syndrome**. ## Management Rationale ### Immediate Seizure Prophylaxis **High-Yield:** Magnesium sulphate is the gold standard anticonvulsant in preeclampsia/eclampsia and reduces maternal mortality and morbidity by ~50%. - **Regimen:** 4 g IV bolus over 20 minutes, followed by 1 g/hour maintenance infusion - **Mechanism:** Stabilizes cell membranes; reduces cerebral vasospasm and seizure threshold - **Efficacy:** Superior to phenytoin and diazepam in preventing eclamptic seizures [cite:Williams Obstetrics 26e Ch 34] ### Delivery Timing **Clinical Pearl:** At 34 weeks with severe preeclampsia/HELLP, delivery is indicated within 24 hours (after antenatal corticosteroids for fetal lung maturity if time permits) regardless of maternal or fetal condition stability. - Maternal complications (eclampsia, pulmonary edema, placental abruption, DIC) escalate with expectant management - Fetal benefit of additional in-utero maturation is outweighed by maternal risk ### Why NOT Oral Nifedipine or Methyldopa Alone? - **Oral nifedipine:** Inadequate for seizure prophylaxis; does not replace magnesium sulphate - **Methyldopa:** Slow-acting (4–6 hours to peak); inappropriate for severe hypertension or seizure prevention; used only in chronic hypertension ### Why NOT Labetalol as First-Line? - **Labetalol:** Excellent for acute hypertensive control but does NOT provide seizure prophylaxis - **Role:** Used AFTER magnesium sulphate is initiated if BP remains >160/110 mmHg ## Mnemonic: HELLP Syndrome **HELLP** = **H**emolysis, **E**levated **L**iver enzymes, **L**ow **P**latelets - Hemolysis: microangiopathic hemolytic anemia (schistocytes on blood smear) - Elevated liver enzymes: AST/ALT >2× upper limit of normal - Low platelets: <100,000/μL --- ## Summary **Magnesium sulphate + delivery within 24 hours** is the standard of care for severe preeclampsia/HELLP syndrome because it prevents eclamptic seizures (the most life-threatening maternal complication) and allows time for antenatal corticosteroids while minimizing maternal risk.